miRNAs Related to Immune Checkpoint Inhibitor Response: A Systematic Review
International Journal of Molecular Sciences · 01.02.2024 · 25 (3) · 1737
DOI: 10.3390/ijms25031737 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.02.2024. Verfasst von José Luis García-Giménez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain. Hauptthemen laut MEDLINE: MicroRNAs, Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UV-La Fe, UV-La Fe 2022 Programa PROYECTOS DE INNOVACIÓN.
Abstract (Originalsprache)
The advent of immune checkpoint inhibitors (ICIs) has represented a breakthrough in the treatment of many cancers, although a high number of patients fail to respond to ICIs, which is partially due to the ability of tumor cells to evade immune system surveillance. Non-coding microRNAs (miRNAs) have been shown to modulate the immune evasion of tumor cells, and there is thus growing interest in elucidating whether these miRNAs could be targetable or proposed as novel biomarkers for prognosis and treatment response to ICIs. We therefore performed an extensive literature analysis to evaluate the clinical utility of miRNAs with a confirmed direct relationship with treatment response to ICIs. As a result of this systematic review, we have stratified the miRNA landscape into (i) miRNAs whose levels directly modulate response to ICIs, (ii) miRNAs whose expression is modulated by ICIs, and (iii) miRNAs that directly elicit toxic effects or participate in immune-related adverse events (irAEs) caused by ICIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain.
- INCLIVA Health Research Institute, INCLIVA, 46010 Valencia, Spain.
- Consortium Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, 46010 Valencia, Spain.
- Department of Biology, Faculty of Nature, Life and Earth Sciences, University of Djillali Bounaama, Khemis Miliana 44225, Algeria.
- Department of Physiology, Faculty of Pharmacy, University of Valencia, 46100 Burjassot, Spain.
- Biomarkers and Precision Medicine Unit, Health Research Institute-Hospital La Fe, 46026 Valencia, Spain.
ORCID-Profile: José Luis García-Giménez, Angel L Ortega, Agustin Lahoz, Guillermo Suay, Javier Pereda, Ahlam Fatmi, Federico V Pallardó
Förderung
- UV-La Fe
- UV-La Fe 2022 Programa PROYECTOS DE INNOVACIÓN
Zitieren
APA
García-Giménez, J. L., Saadi, W., Ortega, A. L., Lahoz, A., Suay, G., Carretero, J., Pereda, J., Fatmi, A., Pallardó, F. V., & Mena-Molla, S. (2024). miRNAs Related to Immune Checkpoint Inhibitor Response: A Systematic Review. International Journal of Molecular Sciences, 25(3), 1737. https://doi.org/10.3390/ijms25031737
Vancouver
García-Giménez JL, Saadi W, Ortega AL, Lahoz A, Suay G, Carretero J, et al. miRNAs Related to Immune Checkpoint Inhibitor Response: A Systematic Review. International Journal of Molecular Sciences. 2024;25(3):1737. doi:10.3390/ijms25031737
BibTeX
@article{GarcaGimnez2024,
author = {García-Giménez, José Luis and Saadi, Wiam and Ortega, Angel L and Lahoz, Agustin and Suay, Guillermo and Carretero, Julián and Pereda, Javier and Fatmi, Ahlam and Pallardó, Federico V and Mena-Molla, Salvador},
title = {miRNAs Related to Immune Checkpoint Inhibitor Response: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1737},
doi = {10.3390/ijms25031737}
}
EUVIMED